Company intelligence / Profile preview

Norcliffe Capital

London, England, United Kingdom

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Norcliffe Capital is an active UK-based venture capital firm specializing in private investments supporting high-growth companies in the medtech and biotechnology sectors, providing capital and strategic support to enable development and commercialization of life-changing medical technologies. The firm operates under the Enterprise Investment Scheme (EIS) and has raised and deployed significant funds into early- and growth-stage companies, typically at preclinical, clinical, and commercial expansion phases.

Industry: Investors

Partnerships

Laverock TherapeuticsDxcover

Beyond the preview

Go deeper on Norcliffe Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norcliffe Capital.

Explore the full profile